The American pharmaceutical company Pfizer, which together with German partner BioNTech has developed a vaccine against coronavirus, will provide India with medicines for $ 70 million, the head of the company, Albert Burla, said in a video message posted on Twitter .
According to him, the people of India are faced with “a humanitarian crisis that has become one of the most severe consequences of the COVID-19 pandemic.”
“In this regard, we are launching the largest humanitarian campaign in the history of Pfizer,” said Burla.
We are all following with deep concern the critical #COVID19 situation in India and @Pfizer is doing everything possible to provide support. https://t.co/SoJeWaLz75
— AlbertBourla (@AlbertBourla) May 3, 2021
The company will provide the Indian authorities with $ 70 million worth of in-house medicines needed to treat coronavirus patients. The company estimates that this stock will be enough to provide medicines to all COVID-19 patients in hospitals across the country for at least 90 days. …
On May 1, the first batch of Sputnik V coronavirus vaccine was delivered to India . The vaccine was delivered to the airport of Hyderabad. The drug will be sent for regulatory approval and then redistributed for vaccination.
On April 28, RDIF agreed to produce 850 million doses of the vaccine in India. On the same day and the next, Russia sent humanitarian aid to the country. Two flights of the Ministry of Emergency Situations delivered more than 22 tons of cargo to New Delhi, including dozens of devices for generating oxygen, ventilators, medical monitors and medicines.
On May 2, it was reported that 392,488 new cases of coronavirus were recorded in India per day. Also, the country recorded a record number of deaths per day – 3689 cases.
